Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening
Not Applicable
Completed
- Conditions
- Lung Carcinoma
- Interventions
- Behavioral: Educational InterventionBehavioral: Questionnaire Administration
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 292
- Registration Number
- NCT04635761
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening
Phase 1
Completed
- Conditions
- Colorectal Carcinoma
- Interventions
- Other: Community Health ServiceOther: Survey Administration
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 183
- Registration Number
- NCT04607291
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Weight Loss Interventions for Black Adults of Faith
Not Applicable
Completed
- Conditions
- Obesity-Related Malignant Neoplasm
- Interventions
- Behavioral: Lifestyle TherapyOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationOther: Short-Term Fasting
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 44
- Registration Number
- NCT04557540
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship
Phase 1
Completed
- Conditions
- Stage I Bladder Cancer AJCC v8Stage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8
- Interventions
- Behavioral: Behavioral Dietary InterventionOther: Educational InterventionOther: Questionnaire Administration
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 49
- Registration Number
- NCT04548193
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Nicotine Vapor Specific Sensory Measurement
Completed
- Conditions
- Substance-Related Disorder
- Interventions
- Other: MeasurementOther: Questionnaire Administration
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 42
- Registration Number
- NCT04533542
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma
Not Applicable
Completed
- Conditions
- Plasma Cell Myeloma
- Interventions
- Dietary Supplement: KefirOther: Best PracticeOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 13
- Registration Number
- NCT04530812
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Recruiting
- Conditions
- Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8
- Interventions
- Other: Cytology Specimen Collection ProcedureOther: Diagnostic Laboratory Biomarker AnalysisOther: Medical Chart Review
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 700
- Registration Number
- NCT04526587
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Phase 1
Recruiting
- Conditions
- Advanced Malignant Solid NeoplasmClinical Stage IV Gastroesophageal Junction AdenocarcinomaClinical Stage IVB Gastroesophageal Junction Adenocarcinoma ALocally Advanced Colorectal CarcinomaLocally Advanced Gastroesophageal Junction AdenocarcinomaPostneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 45
- Registration Number
- NCT04511039
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
Phase 4
Active, not recruiting
- Conditions
- Bladder CarcinomaUrinary Tract InfectionRefractory Bladder Carcinoma
- Interventions
- Other: DiaryDrug: Trimethoprim-Sulfamethoxazole
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 89
- Registration Number
- NCT04502095
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
Early Phase 1
Completed
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic Syndrome
- Interventions
- Biological: Trivalent Influenza Vaccine
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 130
- Registration Number
- NCT04484532
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States